Cleared Special

K110030 - EXPECT ENDOSCOPIC ASPIRATION NEEDLE

K110030 is the FDA 510(k) clearance for EXPECT ENDOSCOPIC ASPIRATION NEEDLE by Boston Scientific Corp. It is a Class 2 Gastroenterology & Urology device (product code ODG) cleared through the Special 510(k) pathway after a 7-day FDA review.

K110030 · Boston Scientific Corp · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2011
Decision
7d
Days
Class 2
Risk

K110030 is an FDA 510(k) clearance for the EXPECT ENDOSCOPIC ASPIRATION NEEDLE. Classified as Endoscopic Ultrasound System, Gastroenterology-urology (product code ODG), Class II - Special Controls.

Submitted by Boston Scientific Corp (Marlboro, US). The FDA issued a Cleared decision on January 12, 2011 after a review of 7 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1500 - the FDA gastroenterology and urology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Boston Scientific Corp devices

Submission Details

510(k) Number K110030 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 05, 2011
Decision Date January 12, 2011
Days to Decision 7 days
Submission Type Special
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
123d faster than avg
Panel avg: 130d · This submission: 7d
Pathway characteristics
Modification to existing cleared device. Third-party reviewed.

Device Classification

Product Code ODG Endoscopic Ultrasound System, Gastroenterology-urology
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1500
Definition To Provide Ultrasonic Visualization Of Body Cavities That Can Be Accessed By Endoscope. For Reusable, Flexible Endoscopes In This Product Code, Validated Reprocessing Instructions And Reprocessing Validation Data Must Be Included In A 510(k) Submission (82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Consultant

Intertek Testing Services
PAULA WILKERSON

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - ODG Endoscopic Ultrasound System, Gastroenterology-urology

All 32
Devices cleared under the same product code (ODG) and FDA review panel - the closest regulatory comparables to K110030.
Acquire Endoscopic Ultrasound Fine Needle Biopsy (FNB) Device
K160845 · Boston Scientific Corporation · May 2016
EXPECT SLIMLINE ENDOSCOPIC ULTRASOUND ASPIRATION NEEDLE
K133312 · Boston Scientific Corporation · Jan 2014
EXPECT ENDOSCOPIC ULTRASOUND ASPIRATION NEEDLE
K112198 · Boston Scientific Corporation · Sep 2011
EG-3830UT, VIDEO ULTRASOUND GASTROSCOPE
K031789 · Pentax Precision Instrument Corp. · Aug 2003
EG-3830UT, VIDEO ULTRASOUND GASTROSCOPE
K023401 · Pentax Precision Instrument Corp. · Feb 2003
FG-36UX FIBER ULTRASOUND GASTROSCOPE
K021276 · Pentax Precision Instrument Corp. · Sep 2002

Related FDA 510(k) Regulatory Insights

Additional regulatory intelligence related to this FDA 510(k) submission, including predicate strategy, review pathways and device classification guidance.